Xtant Medical Holdings Inc (XTNT)
0.94
+0.04
(+4.27%)
USD |
NYAM |
Apr 26, 16:00
0.94
0.00 (0.00%)
After-Hours: 20:00
Xtant Medical Holdings Enterprise Value: 133.46M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 133.46M |
April 24, 2024 | 131.97M |
April 23, 2024 | 134.44M |
April 22, 2024 | 125.46M |
April 19, 2024 | 124.15M |
April 18, 2024 | 125.09M |
April 17, 2024 | 118.22M |
April 16, 2024 | 118.85M |
April 15, 2024 | 128.06M |
April 12, 2024 | 125.09M |
April 11, 2024 | 130.66M |
April 10, 2024 | 131.19M |
April 09, 2024 | 137.34M |
April 08, 2024 | 139.78M |
April 05, 2024 | 139.30M |
April 04, 2024 | 145.81M |
April 03, 2024 | 144.08M |
April 02, 2024 | 144.95M |
April 01, 2024 | 150.20M |
March 28, 2024 | 168.43M |
March 27, 2024 | 160.61M |
March 26, 2024 | 154.10M |
March 25, 2024 | 151.50M |
March 22, 2024 | 150.16M |
March 21, 2024 | 151.46M |
Date | Value |
---|---|
March 20, 2024 | 154.06M |
March 19, 2024 | 154.06M |
March 18, 2024 | 159.27M |
March 15, 2024 | 167.08M |
March 14, 2024 | 164.48M |
March 13, 2024 | 161.88M |
March 12, 2024 | 161.88M |
March 11, 2024 | 161.88M |
March 08, 2024 | 169.69M |
March 07, 2024 | 164.48M |
March 06, 2024 | 161.88M |
March 05, 2024 | 165.78M |
March 04, 2024 | 172.29M |
March 01, 2024 | 168.38M |
February 29, 2024 | 159.27M |
February 28, 2024 | 181.40M |
February 27, 2024 | 169.69M |
February 26, 2024 | 160.57M |
February 23, 2024 | 151.46M |
February 22, 2024 | 135.84M |
February 21, 2024 | 142.37M |
February 20, 2024 | 151.46M |
February 16, 2024 | 154.06M |
February 15, 2024 | 154.06M |
February 14, 2024 | 154.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
39.25M
Minimum
Jun 24 2022
389.90M
Maximum
Feb 26 2021
106.90M
Average
94.32M
Median
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 931.55M |
Retractable Technologies Inc | -13.79M |
InfuSystems Holdings Inc | 190.69M |
Asensus Surgical Inc | 44.48M |
Catheter Precision Inc | 0.7844M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -4.303M |
Revenue (Quarterly) | 28.11M |
Total Expenses (Quarterly) | 31.91M |
EPS Diluted (Quarterly) | -0.03 |
Gross Profit Margin (Quarterly) | 60.97% |
Profit Margin (Quarterly) | -15.31% |
Normalized Earnings Yield | -7.409 |